February 15, 2021
Almost half of coronavirus sufferers report depression
Almost half of people testing positive for coronavirus have reported symptoms of depression, according to a new study published in the International Journal of Environmental Research and Public Health.
Researchers from Bangladesh, the United States and Anglia Ruskin University (ARU) in the UK carried out a cross-sectional survey of more than 1,000 Bangladeshi adult coronavirus patients over the course of one month.
A total of 48% of respondents were categorized as having moderate to severe depression, with a higher prevalence in those with persistent symptoms, low family income and poor health status.
A fifth of those surveyed reported having persistent COVID-19 symptoms, the most common of these being diarrhea and fatigue. Around a quarter of patients had attempted to self-medicate their symptoms with over-the-counter medicines, rather than contact health services.
Co-author Professor Shahina Pardhan, Director of Anglia Ruskin University's Vision and Eye Research Institute, said: "Our study found a high number of respondents suffering depression alongside their COVID-19 symptoms, particularly those who were more vulnerable. We know that the World Health Organisation has reported that mental health services across the world have been disrupted by the pandemic, and this study shows the pressing need for these services among those testing positive for the virus."
Follow the latest news on the coronavirus (COVID-19) outbreak More information: Md. Saiful Islam et al. Treatment, Persistent Symptoms, and Depression in People Infected with COVID-19 in Bangladesh, International Journal of Environmental Research and Public Health (2021). DOI: 10.3390/ijerph18041453 Provided by Anglia Ruskin University Citation: Almost half of coronavirus sufferers report depression (2021, February 15) retrieved 15 February 2021 from https://www.pharmac.top/news/2021-02-coronavirus-depression.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only. shares
Feedback to editors